Back to top
more

Cardlytics (CDLX)

(Real Time Quote from BATS)

$3.95 USD

3.95
2,381,033

-1.26 (-24.18%)

Updated Nov 7, 2024 01:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 251)

Industry: Technology Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cardlytics (CDLX) delivered earnings and revenue surprises of 34.00% and 4.14%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Cardlytics (CDLX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Cardlytics (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

F5 Networks, Cardlytics, Sunrun, Canadian Solar and ReneSola highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

F5 Networks, Cardlytics, Sunrun, Canadian Solar and ReneSola highlighted as Zacks Bull and Bear of the Day

Jeremy Mullin headshot

Bear of the Day: Cardlytics (CDLX)

by Jeremy Mullin

Bulls do damage control after poor earnings guide.

New Strong Sell Stocks for August 27th

by Zacks Equity Research

CDLX, UUUU, IVC, PSTX, and CYTK have been added to the Zacks Rank #5 (Strong Sell) List on August 27, 2021

Cardlytics (CDLX) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Cardlytics (CDLX) delivered earnings and revenue surprises of -11.43% and -6.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Cardlytics (CDLX) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Cardlytics (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cardlytics (CDLX) delivered earnings and revenue surprises of -21.43% and 2.04%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cardlytics (CDLX) delivered earnings and revenue surprises of 42.86% and 17.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Cardlytics (CDLX) Q3 Earnings Expected to Decline

by Zacks Equity Research

Cardlytics (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cardlytics, Inc. (CDLX) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 26.92% and -5.21%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Cardlytics, Inc. (CDLX) Q2 Earnings Expected to Decline

by Zacks Equity Research

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cardlytics Inc (CDLX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cardlytics Inc (CDLX) delivered earnings and revenue surprises of -18.18% and 5.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

What Makes Cardlytics, Inc. (CDLX) a New Strong Buy Stock

by Zacks Equity Research

Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Cardlytics (CDLX) Stock Outpacing Its Business Services Peers This Year?

by Zacks Equity Research

Is (CDLX) Outperforming Other Business Services Stocks This Year?

Cardlytics, Inc. (CDLX) Q4 Earnings Top Estimates

by Zacks Equity Research

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 125.00% and -0.04%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Cardlytics, Inc. (CDLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Verisk (VRSK) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Verisk's (VRSK) fourth-quarter 2019 earnings and revenues are likely to have increased year over year.

Top Ranked Momentum Stocks to Buy for January 22nd

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 22nd

Will Cardlytics Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Cardlytics.

Here's Why Cardlytics, Inc. (CDLX) is a Great Momentum Stock to Buy

by Zacks Equity Research

Does Cardlytics, Inc. (CDLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Cardlytics, Inc. (CDLX) Moves to Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Cardlytics, Inc. (CDLX) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Cardlytics, Inc. (CDLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cardlytics, Inc. (CDLX) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 120.00% and 13.89%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Will Cardlytics, Inc. (CDLX) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.